
Kaysersberg facility’s Lab+ deal expected to bolster CDMO’s filling services

Kaysersberg facility’s Lab+ deal expected to bolster CDMO’s filling services

Non-exclusive deal intends to popularize RTU containment solutions within pharma industry

Deal is valued at $21.9 million

Invests $5 million to upgrade manufacturing processes

Healthcare marketing agency acquisition augments company’s commercialization portfolio

Agreement featuring UK pharma services consultancy intends to grow PharmaLex's pan-European market access presence

HCP-driven partnership calls for greater engagement across the life science sector

Distributor is able to reach more patients as a result

With deal, drug wholesaler grows its biopharma services platform

With integrated supply chain platform, strategic partnership looks to accelerate cell therapy program development

Collaboration will be powered by tech company’s AI services

Acquisition helps grow its CDMO capabilities

Professor Laura Empson pulls back the curtain on insecure overachieving professionals and explains how they can come to accept damaging patterns of overwork as inevitable and even desirable

Financial commitment expected to benefit capabilities of single-use assemblies

Allows CDMO’s regulatory, consulting services to further expand into the pharma market

Among goals, product aims to mitigate supply chain risk for pharma and biotech industries

Location expands company’s pharmacovigilance, regulatory affairs services

Professor Barry Nalebuff of the Yale School of Management explains what is really at stake in any negotiation and ensures you get your half

Chandra Briggman talks about her achievements and future plans as president and CEO of Activation Capital, which supports local and regional efforts to grow a high-growth entrepreneurship community in the Richmond, VA area

Partnership adds technological offerings to PharmaLex’s repertoire

In deal to be finalized by October, purchases B Medical Systems for $423 million

Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID

A look into one of the East Coast’s major life science hubs

Contract sales organizations are evolving alongside the companies they serve

Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity